ABVC BioPharma (ABVC) Doubles Assets to $16.2M in Q2 2025
ABVC BioPharma Inc. (NASDAQ:ABVC) is a clinical-stage biopharmaceutical company that operates at the intersection of pharmaceutical innovation and…
Browsing Tag